CCASAnet works to understand the HIV epidemic in Latin America and the Caribbean
The Caribbean, Central and South America network for HIV epidemiology (CCASAnet) brings together the expertise and resources of Vanderbilt University and clinical and research sites in Argentina, Brazil, Chile, Haiti, Honduras, Mexico and Peru. The goal of the CCASAnet project is to create a shared repository of HIV data from Central and South America and the Caribbean, to use the combined data to answer questions about the characteristics of the regional HIV epidemic, and to work together to improve the quality and consistency of clinical research activities at all member sites.
Regional Member of the
International Epidemiologic Databases to Evaluate AIDS
Recent Publications
76770
1
national-library-of-medicine-grant-proposals
3
default
2809
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22C8FR8XAF%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pellegrino%20et%20al.%22%2C%22parsedDate%22%3A%222025-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%20%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BPellegrino%20RA%2C%20Tu%20S%2C%20Ville-Benavides%20R%2C%20Jalil%20EM%2C%20Sudenga%20SL%2C%20Crabtree-Ram%26%23xED%3Brez%20B%2C%20Cortes%20CP%2C%20Varela%20D%2C%20Hilaire%20G%2C%20Riviere%20C%2C%20Gotuzzo%20E%2C%20Shepherd%20BE%2C%20Fink%20V%2C%20Castilho%20JL%2C%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20Epidemiology.%20Incidence%20and%20outcomes%20of%20anal%20and%20cervical%20cancer%20among%20adults%20with%20HIV%20in%20Latin%20America%3A%20a%20retrospective%20cohort%20study.%20J%20Int%20AIDS%20Soc.%202025%20Oct%3B28%2810%29%3Ae70050.%20PMCID%3A%20PMC12514557%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Incidence%20and%20outcomes%20of%20anal%20and%20cervical%20cancer%20among%20adults%20with%20HIV%20in%20Latin%20America%3A%20a%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachael%20A.%22%2C%22lastName%22%3A%22Pellegrino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengxin%22%2C%22lastName%22%3A%22Tu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Ville-Benavides%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%20M.%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Staci%20L.%22%2C%22lastName%22%3A%22Sudenga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Varela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%22%2C%22lastName%22%3A%22Hilaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Riviere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20Epidemiology%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Human%20papillomavirus%20%28HPV%29-associated%20cervical%20and%20anal%20cancers%20disproportionately%20affect%20people%20with%20HIV%20%28PWH%29.%20This%20study%20aimed%20to%20determine%20the%20incidence%20trends%20of%20and%20risk%20factors%20for%20these%20malignancies%20in%20PWH%20in%20Latin%20America.%5CnMETHODS%3A%20We%20included%20PWH%20from%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20who%20contributed%20person-time%20between%202000%20and%202019.%20We%20calculated%20crude%20and%20age-standardized%20incidence%20rates%2C%20examining%20trends%20over%20time%20with%20Poisson%20regression.%20Adjusted%20hazard%20ratios%20were%20calculated%20using%20Cox%20proportional%20hazard%20models%20with%20propensity%20score%20adjustment.%20We%20calculated%20the%20probability%20of%20survival%20after%20cancer%20diagnosis%20using%20Kaplan-Meier%20curves.%20To%20understand%20factors%20that%20influence%20our%20results%2C%20we%20surveyed%20all%20adult%20CCASAnet%20sites%20on%20current%20practices%20of%20cervical%20and%20anal%20cancer%20screening.%5CnRESULTS%3A%20Overall%2C%205739%20females%20with%20HIV%20%2843%2C417%20person-years%29%20were%20included%20in%20cervical%20cancer%20analyses.%20There%20were%2027%20incident%20cervical%20cancers%3A%20crude%20incidence%20rate%20of%2062.2%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%2034.9-89.4%29%20per%20100%2C000%20person%20years.%20In%20the%20anal%20cancer%20analysis%2C%2012%2C489%20males%20who%20have%20sex%20with%20men%20%28MSM%29%2C%207324%20males%20other%20than%20MSM%20and%205739%20females%20were%20included%20for%20a%20total%20of%2025%2C552%20PWH%2C%20contributing%20157%2C166%20person-years.%20Anal%20cancer%20was%20diagnosed%20in%2056%20individuals%3A%20crude%20incidence%20rates%20of%2059.1%20%5B95%25%20CI%3A%2033.2-85.0%5D%2C%2020.7%20%5B95%25%20CI%3A%2011.6-29.7%5D%20and%2015.2%20%5B95%25%20CI%3A%208.6-21.9%5D%20per%20100%2C000%20person-years%20in%20MSM%2C%20females%20and%20males%20other%20than%20MSM%2C%20respectively.%20Age-standardized%20incidence%20rates%20did%20not%20significantly%20change%20over%20time.%20Anal%20cancer%20risk%20decreased%20significantly%20with%20higher%20time-updated%20CD4%20cell%20count.%20The%20predicted%20probability%20of%205-year%20survival%20after%20cancer%20diagnosis%20was%2072.6%25%20%2895%25%20CI%3A%2048.4-86.8%29%20for%20cervical%20cancer%20and%2058.5%25%20%2895%25%20CI%3A%2044.0-70.5%29%20for%20anal%20cancer.%5CnCONCLUSIONS%3A%20In%20one%20of%20the%20few%20reports%20outside%20the%20United%20States%20or%20Europe%2C%20we%20did%20not%20observe%20a%20decrease%20in%20age-standardized%20incidence%20rates%20for%20anal%20and%20cervical%20cancer%20between%202000%20and%202019.%20These%20data%20support%20continued%20efforts%20for%20cancer%20prevention%20through%20access%20to%20gender-neutral%20HPV%20vaccination%20and%20cancer%20screening.%22%2C%22date%22%3A%222025-10%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.70050%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22NIH2BY4S%22%5D%2C%22dateModified%22%3A%222025-12-16T17%3A10%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22FYCU6796%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lancaster%20et%20al.%22%2C%22parsedDate%22%3A%222024-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%20%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BLancaster%20KE%2C%20Stockton%20M%2C%20Remch%20M%2C%20Wester%20CW%2C%20Nash%20D%2C%20Brazier%20E%2C%20Adedimeji%20A%2C%20Finlayson%20R%2C%20Freeman%20A%2C%20Hogan%20B%2C%20Kasozi%20C%2C%20Kwobah%20EK%2C%20Kulzer%20JL%2C%20Merati%20T%2C%20Tine%20J%2C%20Poda%20A%2C%20Succi%20R%2C%20Twizere%20C%2C%20Tlali%20M%2C%20Groote%20P%20von%2C%20Edelman%20EJ%2C%20Parcesepe%20AM%2C%20IeDEA%20Consortium.%20Availability%20of%20substance%20use%20screening%20and%20treatment%20within%20HIV%20clinical%20sites%20across%20seven%20geographic%20regions%20within%20the%20IeDEA%20consortium.%20Int%20J%20Drug%20Policy.%202024%20Feb%3B124%3A104309.%20PMCID%3A%20PMC10939808%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20substance%20use%20screening%20and%20treatment%20within%20HIV%20clinical%20sites%20across%20seven%20geographic%20regions%20within%20the%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%22%2C%22lastName%22%3A%22Remch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Finlayson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Breanna%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%20Lewis%22%2C%22lastName%22%3A%22Kulzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuti%22%2C%22lastName%22%3A%22Merati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judiacel%22%2C%22lastName%22%3A%22Tine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%20von%22%2C%22lastName%22%3A%22Groote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jennifer%22%2C%22lastName%22%3A%22Edelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Overwhelming%20evidence%20highlights%20the%20negative%20impact%20of%20substance%20use%20on%20HIV%20care%20and%20treatment%20outcomes.%20Yet%2C%20the%20extent%20to%20which%20alcohol%20use%20disorder%20%28AUD%29%20and%20other%20substance%20use%20disorders%20%28SUD%29%20services%20have%20been%20integrated%20within%20HIV%20clinical%20settings%20is%20limited.%20We%20describe%20AUD%5C%2FSUD%20screening%20and%20treatment%20availability%20in%20HIV%20clinical%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20In%202020%2C%20223%20IeDEA%20HIV%20clinical%20sites%20from%2041%20countries%20across%20seven%20geographic%20regions%20completed%20a%20survey%20on%20capacity%20and%20practices%20related%20to%20management%20of%20AUD%5C%2F%20SUD.%20Sites%20provided%20information%20on%20AUD%20and%20other%20SUD%20screening%20and%20treatment%20practices.%5CnRESULTS%3A%20Sites%20were%20from%20low-income%20countries%20%2823%25%29%2C%20lower-middle-income%20countries%20%2838%25%29%2C%20upper-middle%20income%20countries%20%2817%25%29%20and%20high-income%20counties%20%2823%25%29.%20AUD%20and%20SUD%20screening%20using%20validated%20instruments%20were%20reported%20at%2032%25%20%28n%3D71%20located%20in%2012%20countries%29%20and%2012%25%20%28n%3D27%20located%20in%206%20countries%29%20of%20the%20223%20sites%20from%2041%20countries%2C%20respectively.%20The%20North%20American%20region%20had%20the%20highest%20proportion%20of%20clinics%20that%20reported%20AUD%20screening%20%2876%25%29%2C%20followed%20by%20East%20Africa%20%2846%25%29%3B%20none%20of%20the%20sites%20in%20West%20or%20Central%20Africa%20reported%20AUD%20screening.%2031%25%20%28n%3D69%29%20reported%20both%20AUD%20screening%20and%20counseling%2C%20brief%20intervention%2C%20psychotherapy%2C%20or%20Screening%2C%20Brief%20Intervention%2C%20and%20Referral%20to%20Treatment%3B%208%25%20%28n%3D18%29%20reported%20AUD%20screening%20and%20detox%20hospitalization%3B%20and%2010%25%20%28n%3D24%29%20reported%20both%20AUD%20screening%20and%20medication.%20While%20the%20proportion%20of%20clinics%20providing%20treatment%20for%20SUD%20was%20lower%20than%20those%20treating%20AUD%2C%20the%20prevalence%20estimates%20of%20treatment%20availability%20were%20similar.%5CnCONCLUSIONS%3A%20Availability%20of%20screening%20and%20treatment%20for%20AUD%5C%2FSUD%20in%20HIV%20care%20settings%20is%20limited%2C%20leaving%20a%20substantial%20gap%20for%20integration%20into%20ongoing%20HIV%20care.%20A%20critical%20understanding%20is%20needed%20of%20the%20multilevel%20implementation%20factors%20or%20feasible%20implementation%20strategies%20for%20integrating%20screening%20and%20treatment%20of%20AUD%5C%2FSUD%20into%20HIV%20care%20settings%2C%20particularly%20for%20resource-constrained%20regions.%22%2C%22date%22%3A%222024-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.drugpo.2023.104309%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221873-4758%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22NIH2BY4S%22%5D%2C%22dateModified%22%3A%222025-12-16T17%3A09%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22CZ49Z8CX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Belaunzar%5Cu00e1n-Zamudio%20et%20al.%22%2C%22parsedDate%22%3A%222025-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%20%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BBelaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Rebeiro%20PF%2C%20Caro-Vega%20Y%2C%20Castilho%20J%2C%20Crabtree-Ram%26%23xED%3Brez%20BE%2C%20Cesar%20C%2C%20Cortes%20CP%2C%20Mej%26%23xED%3Ba%20F%2C%20Luque%20MT%2C%20Rouzier%20V%2C%20Calvet%20G%2C%20McGowan%20CC%2C%20Sierra-Madero%20J.%20Transitions%20through%20the%20HIV%20continuum%20of%20care%20in%20people%20enrolling%20in%20care%20with%20advanced%20HIV%20disease%20in%20Latin%20America.%20IJID%20Reg.%202025%20Mar%3B14%3A100550.%20PMCID%3A%20PMC11772978%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transitions%20through%20the%20HIV%20continuum%20of%20care%20in%20people%20enrolling%20in%20care%20with%20advanced%20HIV%20disease%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%22%2C%22lastName%22%3A%22Calvet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Advanced%20HIV%20disease%20%28AHD%29%20at%20HIV%20care%20enrollment%20is%20common%20in%20Latin%20America%20and%20may%20bias%20cross-sectional%20care%20continuum%20estimates.%20We%20therefore%20explored%20the%20impact%20of%20AHD%20on%20HIV%20care%20continuum%20outcomes%20using%20a%20longitudinal%20approach.%5CnMETHODS%3A%20We%20analyzed%20trajectories%20of%2026%2C174%20adult%20people%20with%20HIV%20enrolled%20at%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20sites%20%282003-2019%29%20using%20multi-state%20Cox%20regression%20across%20five%20stages%3A%20%28i%29%20enrolled%20without%20antiretroviral%20therapy%20%28no-ART%29%3B%20%28ii%29%20on%20ART%20without%20viral%20suppression%20%28viral%20load%20%5Cu2265200%20copies%5C%2Fm%3B%20ART%20%2B%20non-VS%29%3B%20%28iii%29%20on%20ART%20with%20viral%20suppression%20%28viral%20load%20%26lt%3B200%20copies%5C%2Fml%3B%20ART%20%2B%20VS%29%3B%20%28iv%29%20lost%20to%20follow-up%3B%20%28v%29%20death.%20We%20defined%20AHD%20as%20clusters%20of%20differentiation%204%2B%20count%20%26lt%3B200%20cells%5C%2F%5Cu00b5l%20and%5C%2For%20an%20AIDS-defining%20illness%20at%20enrollment.%5CnRESULTS%3A%20People%20with%20HIV%20with%20AHD%20had%20a%20shorter%20time%20with%20no-ART%2C%20a%20similar%20time%20ART%20%2B%20non-VS%2C%20but%20less%20time%20ART%20%2B%20VS%20before%202013%20than%20non-AHD.%20After%202013%2C%20time%20with%20no-ART%20decreased%20but%20the%205-year%20probability%20of%20transitioning%20from%20no-ART%20to%20ART%20%2B%20VS%20decreased%20in%20both%20groups.%20The%20time%20spent%20virally%20suppressed%20while%20in%20care%20was%20low%2C%20overall.%20Risk%20of%20loss%20to%20follow-up%20and%20death%20was%20persistently%20worse%20among%20adults%20with%20AHD.%5CnCONCLUSIONS%3A%20Using%20a%20longitudinal%20approach%20to%20assess%20the%20HIV%20continuum%20of%20care%20provided%20insight%20into%20limitations%20in%20HIV%20care%20provision%20in%20our%20region%20previously%20underexplained%20by%20cross-sectional%20assessments.%22%2C%22date%22%3A%222025-03%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijregi.2024.100550%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222772-7076%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22NIH2BY4S%22%5D%2C%22dateModified%22%3A%222025-12-15T16%3A11%3A19Z%22%7D%7D%5D%7D
1.
Pellegrino RA, Tu S, Ville-Benavides R, Jalil EM, Sudenga SL, Crabtree-Ramírez B, Cortes CP, Varela D, Hilaire G, Riviere C, Gotuzzo E, Shepherd BE, Fink V, Castilho JL, Caribbean, Central and South America network for HIV Epidemiology. Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study. J Int AIDS Soc. 2025 Oct;28(10):e70050. PMCID: PMC12514557
1.
Lancaster KE, Stockton M, Remch M, Wester CW, Nash D, Brazier E, Adedimeji A, Finlayson R, Freeman A, Hogan B, Kasozi C, Kwobah EK, Kulzer JL, Merati T, Tine J, Poda A, Succi R, Twizere C, Tlali M, Groote P von, Edelman EJ, Parcesepe AM, IeDEA Consortium. Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. Int J Drug Policy. 2024 Feb;124:104309. PMCID: PMC10939808
1.
Belaunzarán-Zamudio PF, Rebeiro PF, Caro-Vega Y, Castilho J, Crabtree-Ramírez BE, Cesar C, Cortes CP, Mejía F, Luque MT, Rouzier V, Calvet G, McGowan CC, Sierra-Madero J. Transitions through the HIV continuum of care in people enrolling in care with advanced HIV disease in Latin America. IJID Reg. 2025 Mar;14:100550. PMCID: PMC11772978
News
[disabled]